Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dr. Sam Robbins, Inc.
WARNING LETTER
•Dr. Sam Robbins, Inc.•June 30, 2020

Dr. Sam Robbins, Inc. – FDA Warning Letter, Jun 30, 2020

Record Details

The FDA issued a Warning Letter to Dr. Sam Robbins regarding products sold on his websites (my4hfl.com, drsamrobbins.com, inflamepainrelief.com, alphaviril.com, healthfitnesslongevity.com), social media, and Amazon storefront. The FDA reviewed these platforms in June 2020.

The primary violation concerns "CholesLo," marketed as a dietary supplement, which FDA lab analyses found to contain lovastatin, an active ingredient in the FDA-approved drug Mevacor®. This renders CholesLo an unapproved new drug under 21 U.S.C. § 321(ff)(3)(B)(i), as lovastatin was approved as a new drug before being marketed as a dietary supplement or food. One sample contained 14.3 mg/capsule, exceeding Mevacor's maximum daily dose if taken as recommended. The FDA has issued a public warning against CholesLo.

Additionally, ten other products—AlphaViril, Blood Flow Optimizer, Blood Pressure Optimizer, Blood Sugar Optimizer, CHEATmeals, Inflame & Pain Relief, LeanOptimizer, Perfect Vitamin D & K, and ProVanax—are deemed unapproved new drugs and misbranded. This is based on claims on labels, websites, social media, and Amazon storefronts that establish their intended use for the cure, mitigation, treatment, or prevention of disease, or to affect body

Company
Dr. Sam Robbins, Inc.
Inspection date
June 30, 2020
Product type
Food
Office
Division of Human and Animal Food Operations - West V
Person
  • Darla R. Bracy
View Company Profile

ID · 5b5ab549-530f-4dcf-a4be-b8e78abe1df4

Violation Codes10
21 U.S.C. 321(ff)(3)(B)(i)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 U.S.C. 353(b)(1)(A)21 CFR 201.521 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Sam Robbins, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.